REDUCEDT+30
Neurocrine Biosciences Inc · NASDAQ
−3,386 sh · $529.0K
Filed 15 Sept 2026SEC Form 4view source
Neurocrine Biosciences Inc · NASDAQ
−3,386 sh · $529.0K
Neurocrine Biosciences Inc · NASDAQ
+6,275 sh
Neurocrine Biosciences Inc · NASDAQ
+3,194 sh · $138.1K
Neurocrine Biosciences Inc · NASDAQ
−2,154 sh · $333.0K